Advanced search
Publication Cover
Infectious Diseases Volume 54, 2022 - Issue 2
Submit an article Journal homepage
3,439
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population – first results from a cohort study in Southern Sweden

Jonas Björka Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden;b Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, SwedenORCID Iconhttps://orcid.org/0000-0003-1883-2000View further author information
ORCID Icon,
Malin Inghammarc Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, SwedenORCID Iconhttps://orcid.org/0000-0003-2995-1312View further author information
ORCID Icon,
Mahnaz Moghaddassid Social Medicine and Global Health, Department of Clinical Sciences Malmö, Lund University, Malmö, SwedenORCID Iconhttps://orcid.org/0000-0002-0844-4736View further author information
ORCID Icon,
Magnus Rasmussenc Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, SwedenORCID Iconhttps://orcid.org/0000-0003-1588-5473View further author information
ORCID Icon,
Ulf Malmqvistb Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, SwedenView further author information
&
Fredrik Kahnc Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5566-6350View further author information
ORCID Icon
Pages 128-133 | Received 12 Jun 2021, Accepted 13 Sep 2021, Published online: 29 Sep 2021

References

  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
  • Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416.
  • Statistik om SARS-CoV-2 virusvarianter av särskild betydelse (in Swedish). Stockholm: Public Health Agency of Sweden; 2021.
  • Hall VJ, Foulkes S, Saei A, et al. Effectiveness of BNT162b2 mRNA Vaccine against infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN study). SSRN 2021.
  • Amit S, Regev-Yochay G, Afek A, et al. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021;397(10277):875–877.
  • Hunter PR, Brainard J. Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel. medRxiv 2021:2021.02.01.21250957.
  • Vasileiou E, Simpson CR, Robertson C, et al. Effectiveness of first dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People. SSRN 2021.
  • Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021;384:1412–1423.
  • Hansen CH, Michlmayr D, Gubbels SM, et al. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397(10280):1204–1212.
  • Hall V, Foulkes S, Charlett A, et al. Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020. medRxiv 2021. DOI:https://doi.org/10.1101/2021.01.13.21249642

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.